Skip to main content

Advertisement

SpringerLink
Log in

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

As evidence-based strategies to the clinical management of Barrett’s esophagus (BE) are lacking, we have carried out a systematic review and meta-analysis of all published randomized controlled trials with the aim of evaluating the value of different approaches in the treatment of BE. Searches were conducted in the databases PUBMED, EMBASE, and Cochrane Library. Thirteen randomized clinical trials that fulfilled the inclusion criteria and addressed the clinical questions of this analysis were assessed in more detail. Based on our search, neither the pharmacological nor surgical therapies currently available for reflux appear to achieve complete regression of BE and the elimination of the cancer risk associated with it. In contrast, endoscopic ablative techniques are capable of achieving endoscopic and histological reversal of BE, with ablation by argon plasma coagulation (APC) appearing to be more effective than treatment with photodynamic therapy (PDT) [odds ratio (OR) 3.46, 95% confidence interval (CI) 1.67–7.81, P = 0.0008]. There was no statistically significant difference between APC and multipolar electrocoagulation (MPEC) in terms of the efficacy to achieve regression of BE (OR 2.01, 95% CI 0.77–5.23, P = 0.15). In conclusion, there have been only a limited number of randomized controlled trials that compare treatments for BE. The pharmacological therapy, antireflux surgery, and endoscopic ablative techniques are promising in terms of treating BE, but the studies carried out to date have had no adequate power to assess the effect of treatment on reducing and preventing progression to adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97(8):1888–1895. doi:10.1111/j.1572-0241.2002.05910.x

    Article  PubMed  Google Scholar 

  2. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 154(4): 965–973. doi: 10.1111/j.1572-0241.2003.07356.x

    PubMed  CAS  Google Scholar 

  3. Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RG, McCarron P, Gavin AT (2003) Mortality in Barrett’s oesophagus: results from population based study. Gut 52(8):1081–1084. doi:10.1136/gut.52.8.1081

    Article  PubMed  CAS  Google Scholar 

  4. Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Rämö OJ, Färkkilä MA, Kivilaakso EO, Mattila SP (1998) Treatment of Barrett’s esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227(1):40–44. doi:10.1097/00000658-199801000-00006

    Article  PubMed  CAS  Google Scholar 

  5. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285(18):2331–2338. doi:10.1001/jama.285.18.2331

    Article  PubMed  CAS  Google Scholar 

  6. Sharma P, Bhattacharyya A, Garewal HS, Sampliner RE (1999) Durability of new squamous epithelium after endoscopic reversal of Barrett’s esophagus. Gastrointest Endosc 50(2):159–164. doi:10.1016/S0016-5107(99)70218-X

    Article  PubMed  CAS  Google Scholar 

  7. Sampliner RE, Faigel D, Fennerty MB, Lieberman D, Ippoliti A, Lewin K, Weinstein WM (2001) Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53(6):554–558. doi:10.1067/mge.2001.114418

    Article  PubMed  CAS  Google Scholar 

  8. Manner H, May A, Miehlke S, Dertinger S, Wigginghaus B, Schimming W, Krämer W, Niemann G, Stolte M, Ell C (2006) Ablation of nonneoplastic Barrett’s mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol 101(8):1762–1769. doi:10.1111/j.1572-0241.2006.00709.x

    Article  PubMed  CAS  Google Scholar 

  9. Pinotti AC, Cecconello I, Filho FM, Sakai P, Gama-Rodrigues JJ, Pinotti HW. (2004) Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 17(3):243–246. doi:10.1111/j.1442-2050.2004.00415.x

    Article  PubMed  CAS  Google Scholar 

  10. van Veen RL, Aalders MC, Pasma KL, Siersema PD, Haringsma J, van de Vrie W, Gabeler EE, Robinson DJ, Sterenborg HJ (2002) In situ light dosimetry during photodynamic therapy of Barrett’s esophagus with 5-aminolevulinic acid. Lasers Surg Med 31(5):299–304. doi:10.1002/lsm.10129

    Article  PubMed  Google Scholar 

  11. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA (2001) Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest Endosc 54(6):682–688

    PubMed  CAS  Google Scholar 

  12. Peters FP, Kara MA, Rosmolen WD, Aalders MC, Ten Kate FJ, Bultje BC, Krishnadath KK, Fockens P, van Lanschot JJ, van Deventer SJ, Bergman JJ (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 61(4):506–514. doi:10.1016/S0016-5107(05)00063-5

    Article  PubMed  Google Scholar 

  13. Eisen GM (2003) Ablation therapy for Barrett’s esophagus. Gastrointest Endosc 58(5):760–769. doi:10.1016/S0016-5107(03)02002-9

    Article  PubMed  Google Scholar 

  14. Morris CD, Byrne JP, Armstrong GR, Attwood SE (2001) Prevention of the neoplastic progression of Barrett’s oesophagus by endoscopic argon beam plasma ablation. Br J Surg 88(10):1357–1362. doi:10.1046/j.0007-1323.2001.01926.x

    Article  PubMed  CAS  Google Scholar 

  15. Ackroyd R, Kelty CJ, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW (2003) Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 35(6):496–501. doi:10.1055/s-2003-39676

    Article  PubMed  CAS  Google Scholar 

  16. Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135(11):982–989

    PubMed  CAS  Google Scholar 

  17. Parrilla P, Martínez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 237(3):291–298. doi:10.1097/00000658-200303000-00001

    Article  PubMed  Google Scholar 

  18. Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH (1999) Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study. Gut 45(4):489–494

    Article  PubMed  CAS  Google Scholar 

  19. Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Marcus SL, Stoddard CJ, Johnson AG, Reed MW (2000) Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 47(5):612–617. doi:10.1136/gut.47.5.612

    Article  PubMed  CAS  Google Scholar 

  20. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62(4):488–498. doi:10.1016/j.gie.2005.06.047

    Article  PubMed  Google Scholar 

  21. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV Jr, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 66(3):460–468. doi:10.1016/j.gie.2006.12.037

    Article  PubMed  Google Scholar 

  22. Ackroyd R, Tam W, Schoeman M, Devitt PG, Watson DI (2004) Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery. Gastrointest Endosc 59(1):1–7. doi:10.1016/S0016-5107(03)02528-8

    Article  PubMed  Google Scholar 

  23. Bright T, Watson DI, Tam W, Game PA, Astill D, Ackroyd R, Wijnhoven BP, Devitt PG, Schoeman MN (2007) Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: late results. Ann Surg 246(6):1016–1020

    Article  PubMed  Google Scholar 

  24. Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW (2004) Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 20(11–12):1289–1296 .doi:10.1111/j.1365-2036.2004.02277.x

    Article  PubMed  CAS  Google Scholar 

  25. Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, Grool TE, van Veen RL, Sterenborg HJ, Kuipers EJ (2004) 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial. Gut 53(6):785–790. doi:10.1136/gut.2003.028860

    Article  PubMed  CAS  Google Scholar 

  26. Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H (2005) Molecular evaluation of ablative therapy of Barrett’s oesophagus. J Pathol 205(1):57–64. doi:10.1002/path.1685

    Article  PubMed  CAS  Google Scholar 

  27. Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I (2005) Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40(7):750–758. doi:10.1080/00365520510015737

    Article  PubMed  Google Scholar 

  28. Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A (2005) Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus. Gastrointest Endosc 61(2):232–240. doi:10.1016/S0016-5107(04)02576-3

    Article  PubMed  Google Scholar 

  29. Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, Prasad A, Sampliner RE (2006) A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 55(9):1233–1239. doi:10.1136/gut.2005.086777

    Article  PubMed  CAS  Google Scholar 

  30. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, Cameron A, Corley D, Falk G, Goldblum J, Hunter J, Jankowski J, Lundell L, Reid B, Shaheen NJ, Sonnenberg A, Wang K, Weinstein W (2004) A critical review of the diagnosis and management of Barrett’s esophagus The AGA Chicago Workshop. Gastroenterology 127(1):310–330. doi:10.1053/j.gastro.2004.04.010

    Article  PubMed  Google Scholar 

  31. Shah AK, Wolfsen HC, Hemminger LL, Shah AA, DeVault KR (2006) Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett’s dysplasia and mucosal carcinoma. Dis Esophagus 19(5):335–339. doi:10.1111/j.1442-2050.2006.00592.x

    Article  PubMed  CAS  Google Scholar 

  32. Shand A, Dallal H, Palmer K, Ghosh S, MacIntyre M (2001) Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 48(4):580–581. doi:10.1136/gut.48.4.580b

    Article  PubMed  CAS  Google Scholar 

  33. Van Laethem JL, Peny MO, Salmon I, Cremer M, Devière J (2000) Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut 46(4):574–577. doi:10.1136/gut.46.4.574

    Article  PubMed  Google Scholar 

  34. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12. doi:10.1016/0197-2456(95)00134-4

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, The First Affiliated Hospital, Medical College, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, P.R. China

    You-Ming Li, Lan Li, Chao-Hui Yu, You-Shi Liu & Cheng-Fu Xu

Authors
  1. You-Ming Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao-Hui Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. You-Shi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cheng-Fu Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to You-Ming Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, YM., Li, L., Yu, CH. et al. A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus. Dig Dis Sci 53, 2837–2846 (2008). https://doi.org/10.1007/s10620-008-0257-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0257-3

Keywords

Search

Navigation